Home News Company news...
April 23, 2024

MEBO International Chairman Kevin Xu Attends the 2024 Concordia Americas Summit

On April 22, Kevin Xu, Chairman of MEBO Group, participated in the prestigious 2024 Concordia Americas Summit held in Miami.

Representing the APEC 2023 Committee as a co-chair, Xu engaged in pivotal discussions with Jorge Quiroga and Laura Chinchilla, former presidents of Bolivia and Costa Rica, respectively.

During these conversations, Xu emphasized the significant influence of the upcoming APEC 2024 conference set to be hosted in Peru, projecting that it will resonate throughout Latin America and catalyze unprecedented development opportunities for this dynamic region. He expressed a strong belief that Latin American nations will utilize this platform to demonstrate their unique strengths and charm to the global community.



About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, Mebo Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, Mebo focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, Mebo's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.


About Kevin Xu

Kevin Xu serves as the CEO of MEBO Group and Skingenix Inc., bringing pioneering advancements in the health and skincare industries. He holds prestigious roles including the Co-Chair of the APEC 2023 Host Committee. Additionally, he is an Executive Board member and Co-Chair of the International Committee at the Bay Area Council, actively shaping international policies and collaborations.

Xu's commitment extends beyond corporate leadership to significant philanthropic and advisory roles. He founds the National Rongxiang Xu Foundation, the Human Heritage Project, and leads initiatives like the California Fight Against Coronavirus. His influence spans academia and policy-making, serving on advisory boards at top institutions like Harvard Medical School and Caltech, and initiatives such as the Kevin Xu Neurotechnology Center.

Recognized globally, Xu contributes to high-profile publications and has been honored at the United Nations and by the White House. His leadership fosters broad societal impact, driving forward both medical innovation and global health initiatives.


About Concordia

Concordia, as a global platform that convenes leaders from government, business, nonprofit sectors, think tanks, and foundations, is committed to finding interdisciplinary solutions to the greatest challenges of our time. Its annual summit, paralleled with the United Nations General Assembly, is noted for its expansive and nonpartisan discourse. Concordia's regional summits, focusing on the Americas, the U.S., Europe, and Africa, offer invaluable opportunities for international dialogue and collaboration.